Filing Details
- Accession Number:
- 0001127602-11-011136
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-03-24 16:42:52
- Reporting Period:
- 2011-03-23
- Filing Date:
- 2011-03-24
- Accepted Time:
- 2011-03-24 16:42:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1106578 | A Martine Rothblatt | C/O United Therapeutics Corporation 1040 Spring Street Silver Spring MD 20910 | Ceo | Yes | Yes | No | No |
Transaction Summary
| Sold: | 8,000 shares | Avg. Price: $65.78 | Total Value: $526,202.40 |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-03-24 | 8,000 | $30.75 | 8,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-03-24 | 8,000 | $65.78 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options | Disposition | 2011-03-23 | 165,214 | $0.00 | 0 | $30.75 |
| Common Stock | Stock Options | Disposition | 2011-03-24 | 8,000 | $0.00 | 8,000 | $30.75 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 856,000 | 2009-12-26 | 2017-12-31 | No | 4 | D | Direct |
| 848,000 | 2009-12-26 | 2017-12-31 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 567,132 | Indirect | By Trusts |
Footnotes
- 165,214 shares underlying the option were cancelled pursuant to a Stipulation of Settlement entered into by the reporting person and certain other parties to a derivative lawsuit in the Delaware Court of Chancery (In re United Therapeutics Corporation Derivative Litigation, Cons. C.A. No. 4946-C).
- Shares held by the reporting person in GRATs and PMTs.
- Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.
- This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
Billionaire Hedge Funds
